Find clinical trials for Multiple Myeloma in Berlin, BE
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Berlin, BE, DEU:
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
The purpose of this study is to evaluate three daratumumab dose schedules in participants with Smoldering Multiple Myeloma....
Phase 2
Berlin, Germany and 56 other locations
(DRd) to that of lenalidomide and dexamethasone (Rd), in terms of progression-free survival in participants with relapsed or refractory multiple...
Phase 3
Berlin, Germany and 145 other locations
Multiple myeloma (MM) is a rare cancer caused by abnormal survival of plasma cells (blood cells). Most trial participants with MM r...
Phase 1
Berlin, Germany and 18 other locations
monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Pa...
Phase 3
Berlin, Germany and 212 other locations
compared with VMP alone in participants with previously untreated multiple myeloma who are ineligible for high dose chemotherapy an...
Phase 3
Berlin, Germany and 164 other locations
The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the t...
Phase 3
Berlin, Germany and 54 other locations
This open-label, randomized study for evaluating the efficacy and safety of single agent belantamab mafodotin when compared to pom/dex in participant...
Phase 3
Berlin, Germany and 140 other locations
The investigators propose this study utilizing Lenalidomide, Adriamycin, Dexamethasone (RAD) as comparator arm for Lenalidomide, Bortezomib, Dexameth...
Phase 3
Berlin, Germany and 31 other locations
A study designed tocompare progression-free survival (PFS) in participants with t(11;14)-positive MM treated with venetoclax in combination with dexa...
Phase 3
Berlin, Germany and 180 other locations
antibody, daratumumab, can provide more benefit to people with multiple myeloma compared to a combination therapy including daratum ...
Phase 3
Berlin, Berlin, Germany and 262 other locations
Clinical trials
Research sites
Resources
Legal